INDOL-3-CARBINOL IN THE TREATMENT OF BENIGN BREAST DISORDERS
123 patients with various forms of fibrocystic mastopathy (n=114) and fibroadenoma of mammry gland (n=9) were enrolled into the study. Indol-3-carbinol (indinol, Close corporation «Mirax-Pharma») was administered in the dose of 300-400 mg per day for 3-6 months. Disappearance of complaints to pain w...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
ABV-press,
2014-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | 123 patients with various forms of fibrocystic mastopathy (n=114) and fibroadenoma of mammry gland (n=9) were enrolled into the study. Indol-3-carbinol (indinol, Close corporation «Mirax-Pharma») was administered in the dose of 300-400 mg per day for 3-6 months. Disappearance of complaints to pain was observed in 35% of patients after 3 months of therapy and in 63% - after 6 months of therapy. Objective signs of fibrocystic mastopathy completely regressed in 9% of patients after 3 months of therapy and in 16% - after 6 month of therapy. Overall considerable improvement of condition or complete cure was seen in 55% of patients after 3 month of treatment and in 92% - after 6 months of therapy. Thus, indinol is highly effective and safe agent for treatment of different types of mastopathy. |
|---|---|
| Item Description: | 1994-4098 1999-8627 10.17650/1994-4098-2008-0-3-50-54 |